Publications

BRAF Apr 17 2024 Paradox-Breaker BRAF inhibitor plixorafenib (FORE8394) synergizes with MEKi in BRAF V600 and non- V600 alterations Read more

BRAF Apr 17 2024 Efficacy of BRAF Inhibitor Plixorafenib (FORE8394) in Recurrent PCNST Read more

BRAF Apr 17 2024 Safety & Efficacy of BRAF Inhibitor FORE8394 Patients w. Advanced Solid & CNS Tumors Read more

BRAF Apr 16 2024 Dose optimization of novel BRAF inhibitor FORE8394 based on PK and efficacy results Read more

BRAF Sep 13 2022 Efficacy of BRAF Inhibitor FORE8394 in BRAF V600+ Patients Read more

KRAS Aug 15 2021 Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer Read more

BRAF May 20 2021 AACR Virtual Annual Meeting I: Insights Gained from AACR Project GENIE Read more

KRAS Apr 14 2021 Functional measurement of mitogen-activated protein kinase pathway activation predicts responsiveness of RAS-mutant cancers to MEK inhibitors Read more

BRAF Aug 15 2020 A systematic analysis of BRAF mutations and their sensitivity to different BRAF inhibitors Read more